The study, accepted for publication by the journal Influenza and Other Respiratory Viruses, reviewed four randomized controlled trials on masks between January 1990 and March.
Researchers found the use of common medical masks did not increase viral respiratory infection or clinical respiratory illness compared to the use of N95 respirator masks during procedures where fine air particles were not generated.
Healthcare workers should wear the fitted N95 respirator masks for procedures during which fine air particles are generated, such as inserting breathing tubes, as national and international guidelines unanimously recommend this, said Mark Loeb, MD, a professor of pathology and molecular medicine at McMaster University in Ontario, Canada.
Researchers said they plan to follow up this study with a multisite randomized controlled trial where nurses will use either a medical mask or N95 respirator mask when caring for patients with fever and respiratory illness.
More articles on infection control:
CDC: 3 ways to decontaminate respirators
Talking, breathing could spread coronavirus, experts tell White House
Some COVID-19 patients only show digestive symptoms, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
